Regorafenib–Avelumab Combination in Patients With Biliary Tract Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
Eur. J. Cancer 2022 Feb 01;162(xx)161-169, S Cousin, C Cantarel, JP Guegan, T Mazard, C Gomez-Roca, JP Metges, C Bellera, A Adenis, I Korakis, PG Poureau, K Bourcier, M Toulmonde, M Kind, C Rey, C Auzanneau, A Bessede, I Soubeyran, A ItalianoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.